Treatment of Budd-Chiari syndrome with occlusion of both inferior vena cava and hepatic veins lesions by interposition of graft meso-caval-atrial shunt

National Medical Journal of China

Volumn 88, Issue 27, 2008, Pages 1912-1915

  Xue, Huan Zhou ^a   Wang, Ya Dong ^a   Jiang, Qing Feng ^a   Zhang, Hong Wei ^a   Shen, Quan ^a  

^a HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Budd Chiari syndrome; Hepatic veins; Portal pressure; Vena cava, inferior

Indexed keywords

ADULT; ARTICLE; BLOOD FLOW; BLOOD PRESSURE; BLOOD VESSEL GRAFT; BUDD CHIARI SYNDROME; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART RIGHT ATRIUM; HUMAN; INFERIOR CAVA VEIN OBSTRUCTION; LIVER VEIN OBSTRUCTION; MAJOR CLINICAL STUDY; MALE; MESOCAVAL SHUNT; PORTAL VEIN; SUPERIOR MESENTERIC VEIN; THERAPY EFFECT; THROMBOSIS; VASCULAR SUTURE; ADOLESCENT; ANASTOMOSIS; BLOOD VESSEL PROSTHESIS; INFERIOR CAVA VEIN; LIVER VEIN; METHODOLOGY; MIDDLE AGED; PATHOLOGY; VASCULAR SURGERY;

ADOLESCENT; ADULT; ANASTOMOSIS, SURGICAL; BLOOD VESSEL PROSTHESIS; BUDD-CHIARI SYNDROME; FEMALE; FOLLOW-UP STUDIES; HEPATIC VEINS; HUMANS; MALE; MIDDLE AGED; VASCULAR SURGICAL PROCEDURES; VENA CAVA, INFERIOR; YOUNG ADULT;

EID: 77954837214     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Marshall JO, Pat OD, Susan LO, et al. A 27-year experience with surgical treatment of Budd-Chiari syndrome. Ann Surg, 2000, 232: 340-352.
2. Rinchenbach S, Chakfe M, Beaufigean M, et al. Surgical treatment of a Budd Chiari syndrome secondary to hepatic inferior vena cava agenesia. J Cardiovasc Surg, 2002, 43: 665-669.
3. Fisher NC, McCafferty I, Dolapci M, et al. Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angio-plasty and surgical shunting. Gut, 1999, 44: 568-574.
4. Bachmann R, Strunk H, Brensing KA, et al. Diagnosis and therapy of Budd-Chiari syndrome. Aktuelle Radiol, 1998, 8: 213-219.
5. Zhang XM, Wang ZG, Wang SH, et al. Interventional or semiinterventional management on Budd-Chiari syndrome (experience of 173 cases). Chin Med Sci J, 2003, 18: 111-115.
6. Segev DL, Nguyen GC, Locke JE, et al. Twenty years of liver transplantation for Budd-Chiari syndrome: a national registry analysis. Liver Transpl, 2007, 13: 1285-1294.
7. Shimoda M, Marubashi S, Dono K, et al. Utilization of autologous vein graft for replacement of the inferior vena cava in living-donor liver transplantation for obliterative hepatocavopathy. Transpl Int, 2007, 20: 804-807.
8. Bachet JB, Condat B, Hagege H, et al. Long-term portosystemic shunt patency as a determinant of outcome in Budd-Chiari syndrome. J Hepatol, 2007, 46: 60-68.
9. Vignali C, Bargellini I, Grosso M, et al. TIPS with expanded polytetrafluoroethylene-covered stent: results of an Italian multicenter study. AJR Am J Roentgenol, 2005, 185: 472-480.
10. Gandini R, Konda D, Simonetti G. Transjugular intrahepatic portosystemic shunt patency and clinical outcome in patients with Budd-Chiari syndrome: covered versus uncovered stents. Radiology, 2006, 241: 298-305. (Pubitemid 44433363)
11. Russle M, Siegerstetter V, Euringer W, et al. The use of a polytetrafluoroethylene-covered stent graft for transjugular intrahepatic portosystemic shunt (TIPS): long-term follow-up of 100 patients. Acta Radiol, 2006. 47: 660-666.
12. Wang ZG, Jones RS. Budd-Chiari syndrome. Curr Probl Surg, 1996, 33: 81-220.